These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5031606)

  • 21. VP-16 and adriamycin in patients with advanced breast cancer.
    Vaughn CB; Maniscalco-Greb E; Lockhard C; Groshko G; Enochs K; Duffin H; Demitrish M
    Am J Clin Oncol; 1982 Oct; 5(5):505-9. PubMed ID: 6897491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T; Rosner D; Diaz R; Dao T; Sponzo R; Cunningham T; Horton J; Simon R
    Cancer; 1978 Jun; 41(6):2073-7. PubMed ID: 657080
    [No Abstract]   [Full Text] [Related]  

  • 24. A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
    Stöger H; Bauernhofer T; Schmid M; Ploner F; Moser R; Derstvenscheg E; Steindorfer P; Wilders-Truschnig M; Kuss I; Samonigg H
    Cancer Chemother Pharmacol; 1994; 35(2):174-8. PubMed ID: 7987997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapy.
    Scialla SJ; Miskoff RA
    JAMA; 1976 May; 235(22):2416-7. PubMed ID: 946650
    [No Abstract]   [Full Text] [Related]  

  • 26. Experience with furanidyl-fluorouracil in advanced tumours of the breast.
    Cichy A; Jurga L; Klvana M
    Neoplasma; 1974; 21(6):723-32. PubMed ID: 4614094
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
    Tormey DC; Weinberg VE; Holland JF; Weiss RB; Glidewell OJ; Perloff M; Falkson G; Falkson HC; Henry PH; Leone LA
    J Clin Oncol; 1983 Feb; 1(2):138-45. PubMed ID: 6366133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nursing management--cancer chemotherapy.
    Lane CG
    J Nurs Care; 1980 Oct; 13(10):7-11. PubMed ID: 6903601
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of 5-fluorouracil on small bowel mucosa.
    White RS; Fuqua WB; Barrett O
    J Surg Oncol; 1971; 3(5):501-6. PubMed ID: 5114102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
    Karev N; Blokhina N; Voznyi E; Perscin M
    Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
    [No Abstract]   [Full Text] [Related]  

  • 31. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Konishi K; Yabushita K; Taguchi T; Ota J; Takashima S; Abe T; Kikkawa N; Yasutomi M; Sowa M; Maehara Y
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):925-32. PubMed ID: 7793998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
    Boesen E; Mouridsen HT
    Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigation.
    Farker K; Merkel U; Wedding U; Hippius M; Höffken K; Hoffmann A
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):31-7. PubMed ID: 16425969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
    Lin CC; Cheng AL; Hsu CH; Lu YS; Hsu C; Yeh KH; Wu CY; Huang CS; Yang CH
    Anticancer Res; 2007; 27(1B):641-5. PubMed ID: 17348454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
    Hirshaut Y; Kesselheim H
    Cancer; 1983 Jun; 51(11):1998-2004. PubMed ID: 6687698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Serpentine supravenous fluorouracil hyperpigmentation.
    Hrushesky WJ
    JAMA; 1976 Jul; 236(2):138. PubMed ID: 947001
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.
    Kemeny NE; Ahmed T; Michaelson RA; Harper HD; Yip LC
    J Clin Oncol; 1984 Apr; 2(4):311-5. PubMed ID: 6200577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adriamycin in chemotherapy of solid tumors].
    Lovisetto P; Pochettino G; Biarese V
    Minerva Med; 1975 May; 66(35):1653-63. PubMed ID: 1128811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin (NSC-125066): phase I clinical study.
    Sonntag RW
    Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.